Please login to the form below

Not currently logged in
Email:
Password:

opioid addiction

This page shows the latest opioid addiction news and features for those working in and with pharma, biotech and healthcare.

Reckitt hammered by $1.4bn opioid settlement bill

Reckitt hammered by $1.4bn opioid settlement bill

of its opioid addiction treatment Suboxone. ... Opioid withdrawal is difficult, painful, and sometimes dangerous; people struggling to overcome addiction face challenges that can often seem insurmountable,” commented assistant attorney general Jody

Latest news

  • UK to add addiction warnings to opioids as use soars UK to add addiction warnings to opioids as use soars

    People needed protection "from the darker side to painkillers", he said in a statement yesterday, and referencing the epidemic of opioid addiction that claims thousands of lives every year in the ... The addiction problem has also created a market for

  • Lilly, Pfizer say NGF drug works in back pain too Lilly, Pfizer say NGF drug works in back pain too

    The market for drugs that deliver effective pain relief without the risk of side effects and addiction linked to opioid analgesics could be massive, and that is driving the development of ... In contrast to opioids, which alter pain perception by

  • Brexit contributes to surge in generic drug prices Brexit contributes to surge in generic drug prices

    He says some medicines would be “particularly vulnerable" - highlighting a current shortage of pain and opioid addiction treatment Buprenorphine and antipsychotic Risperidone, arising in particular because there are no simple alternatives

  • FDA awards another non-opioid pain drug breakthrough status FDA awards another non-opioid pain drug breakthrough status

    Second drug fast-tracked amid addiction epidemic. The FDA is prioritising the approval of new non-opioid pain treatments, as part of the US battle against its opioid addiction epidemic. ... prevent more people becoming addicted to opioid painkillers

  • Regeneron and Teva close gap on rivals with NGF pain drug Regeneron and Teva close gap on rivals with NGF pain drug

    Nevertheless, fasinumab and tanezumab are now leading what analysts consider could be a highly-lucrative market for drugs that deliver effective pain relief without the risk of side effects and addiction ... In contrast to opioids, which alter pain

More from news
Approximately 4 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    11. Buvidal – an advance in opioid dependence treatment. Opioid addiction has surged in the US since the 1990s, when prescription drugs such as OxyContin and Vicodin became a common remedy for ... The US market for the treatment of opioid addiction is

  • Pharma deals during November 2014 Pharma deals during November 2014

    Indivior will not be without its challenges as sales of its off-patent opioid addiction treatment Suboxone continue to slump.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • IOTOD: Improving Opioid Dependence Outcomes

    IOTOD’s future. The IOTOD educational initiative perpetually aims to provide the most up-to-date information in the field of opioid addiction. ... in opioid addiction and gain valuable insight on some of the most controversial topics in the field.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics